IL-10-producing T cells suppress immune responses in anergic tuberculosis patients

Journal of Clinical Investigation

Volumn 105, Issue 9, 2000, Pages 1317-1325

  Boussiotis, Vassiliki A ^a,b   Tsai, Eunice Y ^c   Yunis, Edmond J ^a   Thim, Sok ^d   Delgado, Julio C ^a,c   Dascher, Christopher C ^b   Berezovskaya, Alla ^a,b   Roussec, Dominique ^e   Reynes, Jean Marc ^e   Goldfeld, Anne E ^b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c CENTER FOR BLOOD RESEARCH   (United States)

^d Cambodian Health Committee   (Cambodia)

^e INSTITUT PASTEUR DU CAMBODGE   (Cambodia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; MITOGEN ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TUBERCULIN;

ARTICLE; CLONAL ANERGY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOSURVEILLANCE; MAJOR CLINICAL STUDY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUBERCULIN TEST; TUBERCULOSIS;

EID: 12944310982     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9918     Document Type: Article

References (54)

1. Daley, C.L., et al. 1992. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N. Engl. J. Med. 326:231-235.
2. Cisneros, J.R., and Murray, K.M, 1996. Corticosteroids in tuberculosis. Ann. Pharmacother. 30:1298-1303.
3. Bloom, B.R., and Small, P.M. 1998. The evolving relation between humans and Mycobacterium tuberculosis. N. Engl. J. Med. 338:677-678.
4. Karim, M., and Elner, J.J. 1995. Mechanisms of anergy. In Tuberculosis. W.N. Rom and S.M. Garay, editors. Little, Brown & Co. New York, New York, USA. 343-351.
5. Daniel, T. 1991. Tuberculosis. In Harrison's principles of internal medicine. J.D. Wilson et al., editors. McGraw-Hill. New York, New York, USA. 637-645.
6. 1994. World Health Organization (WHO) Report on the TB Epidemic. Geneva, Switzerland.
7. Mueller, D.L., Jenkins, M.K., and Schwartz, R.H. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7:445-480.
8. Jenkins, M.K., and Schwartz, R.H. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302-319.
9. Schwartz, R.H. 1996. Models of T cell anergy: is there a common molecular mechanism? J. Exp. Med. 184:1-8.
10. Migita, K., et al. 1995. Defective TCR-mediated signaling in anergic T cells. J. Immunol. 155:5083-5087.
11. Sloan-Lancaster, J., Shaw, A.S., Rothbard, J.B., and Allen, P.M. 1994. Partial T cell signaling: altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy. Cell 79:913-922.
12. Madrenas, J., et al. 1995. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science. 267:515-518.
13. Boussiotis, V.A., et al. 1996. Differential association of protein tyrosine kinases with T cell receptor is linked to the induction of anergy and its prevention by B7 family-mediated costimulation. J. Exp. Med. 184:365-376.
14. Boussiotis, V.A., Freeman, G.J., Berezovskaya, A., Barber, D.L., and Nadler, L.M. 1997. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science. 278:124-128.
15. Miller, C., Ragheb, J.A., and Schwartz, R.H. 1999. Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanism in vivo. J. Exp. Med. 190:53-64.
16. Groux, H., Bigler, M., de Vries, J.E., and Roncarolo, M.G. 1996. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J. Exp. Med. 184:19-29.
17. Groux, H., et al. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:737-742.
18. Goldfeld, A.E., et al. 1998. Association of an HLA-DQ allele with clinical tuber culosis. JAMA. 279:226-228.
19. Boussiotis, V.A., Freeman, G.J., Gray, G., Gribben, J., and Nadler, L.M. 1993. B7 but not ICAM-1 costimulation prevents the induction of human alloantigen specific tolerance. J. Exp. Med. 178:1753-1763.
20. Caruso, A.M., et al. 1999. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 162:5407-5416.
21. Smith, S.M., et al. 1999. Characterization of human Mycobacterium bovis bacille Calmette-Guerin-reactive CD8+ T cells. Infect. Immun. 67:5223-5230.
22. Serbina, N.V., and Flynn, J.L. 1999. Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect. Immun. 67:3980-3988.
23. Chai, J.G., et al. 1999. Anergic T cells act as suppressor cells in vitro and in vivo. Eur. J. Immunol. 29:686-692.
24. Qin, S., et al. 1993. "Infectious" transplantation tolerance. Science. 259:974-977.
25. Flesch, I.E., and Kaufmann, S.H. 1993. Role of cytokines in tuberculosis. Immunobiology. 189:316-339.
26. Torres, M., Herrera, T., Villareal, H., Rich, E.A., and Sada, H. 1998. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis. Infect. Immun. 66:176-180.
27. Verbon, A., et al. 1999. Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol. 115:110-113.
28. Flynn, J.L., et al. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
29. Castro, A.G., Silva, R.A., and Appelberg, R. 1995. Endogenously produced IL-12 is required for the induction of protective T cells during Mycobacterium avium infections in mice. J. Immunol. 155:2013-2019.
30. Flynn, J.L., et al. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:2515-2524.
31. de Jong, R., et al. 1998. Severe mycobacterial and salmonella infections in interleukin-12 receptor-deficient patients. Science. 280:1435-1438.
32. Bonato, V.L., Lima, V.M.F., Tascon, R.E., Lowrie, D.B., and Silva, C.L. 1998. Identification and characterization of protective T cells in hsp65 DNA vaccinated and Mycobacterium tuberculosis infected mice. Infect. Immun. 66:169-175.
33. Baliko, Z., Szereday, L. and Szekeres-Barrho, J. 1998. Th2 biased immune response in cases with active Mycobacterium tuberculosis infection and tuberculin anergy. FEMS Immunol. Med Microbiol. 22:199-204.
34. Rojas, M., Olivier, M., Gros, P., Barrera, L.F., and Garcia, L.F. 1999. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J. Immunol. 162:6122-6131.
35. Chensue, S.W., Warmington, K.S., Ruth, J.H., Lincoln, P., and Kunkel, S.L. 1995. Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Local and regional participation of IFN-gamma, IL-10, and TNF. J. Immunol. 154:5969-5976.
36. Zeller, J.C., et al. 1999. Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-b. J. Immunol. 163:3684-3691.
37. Boussiotis, V.A., et al. 2000. p27kip1 functions as an anergy factor inhibiting IL-2 transcription and clonal expansion of alloreactive human and murine helper T lymphocytes. Nat. Med 6:290-297.
38. Li, W., Whaley, C.D., Mondino, A., and Mueller, D.L. 1996. Blocked signal transduction to the ERK and JNK protein kinases in anergic CD4+ T cells. Science. 271:1272-1276.
39. Fields, P.E., Gajewski, T.F., and Fitch, F.W. 1996. Blocked Ras activation in anergic CD4+ T cells. Science. 271:1276-1278.
40. Warne, P.H., Rodriguez Viciana, P.R., and Downward, J. 1993. Direct interaction of Ras and the aminoterminal region of Raf-1 in vitro. Nature. 364:352-355.
41. Stokoe, D., Macdonald, S.G., Cadwallader, K., Symonsa, M., and Hancock, J.F. 1994. Activation of Ras as a result of recruitment to the plasma membrane. Science. 264:1463-1467.
42. Alessi, D.R., et al. 1994. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74 raf-1. EMBO J. 13:1610-1619.
43. Newport, M., et al. 1996. A mutation in the interferon-g-receptor gene and susceptibility to mycobacterial infection. N. Engl. Med. 335:1941-1949.
44. Jouanguy, E., et al. 1996. Interferon - receptor deficiency in an infant with fatal bacille Camelete-Guerin infection. N. Engl. J. Med 335:1956-1961.
45. Cooper, A.M., et al. 1993. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med 178:2243-2247.
46. Bloom, B.R., and McKinney, J.D. 1999. The death and resurrection of tuberculosis. Nat. Med. 5:872-874.
47. Murray, P.J., Wang, L., Onufryk, C., Tepper, R.I., and Young, R.A. 1997. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J. Immunol. 158:315-321.
48. Murray, P.J., and Young, R.A. 1999. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect. Immun. 67:3087-3095.
49. Plebanski, M., et al. 1999. Interleukin 10-mediated immunosuppression by a variant CD4 T cell epitope of Plasmodium falciparum. Immunity. 10:651-660.
50. Larsen, C.P., et al. 1996. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature. 381:434-438.
51. Kirk, A.D., et al. 1997. CTLA4-1g and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. USA. 94:8789-8794.
52. Blazar, B.R., Taylor, P.A., Linsley, P.S., and Vallera, P.A. 1994. In vivo blockade of CD28/CTLA4: B7/BB1 interaction with (TLA4-1g reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice. Blood. 83:3815-3825.
53. Blazar, B.R., Taylor, P., Noelle, R.J., and Vallera, D.A. 1998. CD4+ T cells tolerized ex-vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host lethality capacity but retain normal antigen responses. J. Clin. Invest. 102:473-482.
54. Guinan, E.C., et al. 1999. Transplantation of anergic histoincompatible bone marrow allografts. N. Engl. J. Med. 340:1704-1714.